Type 2 & other diabetes

1. Diabetes Res Clin Pract21 Jul 2026

   Glucagon-like peptide-1 receptor agonists and new-onset atrial fibrillation in adults with diabetes or obesity: a multinational cohort study

   Cohort study

2. J Diabetes Sci Technol21 Jul 2026

   Long-term Performance of a Dynamic Clinical Decision Support System for Intravenous Insulin Therapy: A Retrospective Cohort Study in Patients With and Without Diabetes

   Cohort study

3. J Clin Endocrinol Metab21 Jul 2026

   Oral semaglutide and CV benefits in the SOUL trial: how do baseline or changes in HbA1c and BMI affect clinical outcomes?

   Secondary analysis

4. Diabetes Obes Metab21 Jul 2026

   Safety Signals of GLP ‐1 Receptor Agonists: A Multi‐Method Pharmacovigilance Analysis of FAERS (2018–2025) With Sensitivity‐Stratified Prioritisation, Notoriety‐Bias Assessment, and Cross‐Database Validation

   Diagnostic or prognostic study

5. Diabetologia20 Jul 2026

   Acute mild cold exposure with shivering reduces 24 h glucose levels in individuals with type 2 diabetes but not prediabetes

   Randomized controlled trial

6. Diabetes Obes Metab20 Jul 2026

   A Real‐World Cohort Study on the Association of the Use of Sodium‐Glucose Cotransporter‐2 Inhibitor With the Incidence of Chronic Kidney Disease ( CKD ) in Patients With Type 2 Diabetes Mellitus Without CKD Using the SingHealth Diabetes Registry

   Cohort study

7. Diabetes Obes Metab19 Jul 2026

   Durability and Safety of Imeglimin as an Add‐On to DPP ‐4 Inhibitors in Japanese Type 2 Diabetes: The 104‐Week FAMILIAR Trial

   Randomized controlled trial

8. Diabetes Obes Metab19 Jul 2026

   Efficacy and Safety of iGlarLixi Versus IDegAsp by Baseline Age, Disease Duration and HbA1c in Chinese People With Type 2 Diabetes: Post Hoc Analyses of the Soli‐D Study

   Secondary analysis

9. Diabetes Res Clin Pract18 Jul 2026

   Work participation among Australians with diagnosed type 2 diabetes mellitus

   Cohort study

10. Diabetes Res Clin Pract18 Jul 2026

    Telehealth effectiveness for glycaemic control of older adults with Type 2 diabetes: An integrative review

    Research article

11. Diabetes Res Clin Pract17 Jul 2026

    Prospective cohort study of cancer incidence and related factors among patients with type 2 diabetes in Japan

    Cohort study

12. Diabetes Res Clin Pract17 Jul 2026

    Serum vs. exosomal miRNA signatures in South Asian adults with prediabetes: implications for T2DM risk prediction

    Cohort study

13. Diabetes Res Clin Pract17 Jul 2026

    Genetics and clinical landscape of pediatric monogenic diabetes in consanguineous cohort: high diagnostic yield and recessive burden

    Cross-sectional study

14. Diabetes Care17 Jul 2026

    IgG N-Glycosylation and Incident Neuropathy and Nephropathy in People With Type 2 Diabetes: A Pooled Analysis of Prospective Cohort Studies

    Meta-analysis

15. Diabetologia17 Jul 2026

    Dapagliflozin does not impair LDL catabolism and induces a shift towards a closer to normal VLDL1/VLDL2 catabolism in individuals with type 2 diabetes: a randomised in vivo kinetic study

    Randomized controlled trial

16. Diabetes Care16 Jul 2026

    Blood-Based DNA Methylation Models Improve Short-term Cardiovascular Risk Stratification in Individuals With Type 2 Diabetes

    Diagnostic or prognostic study

17. Diabetes Res Clin Pract16 Jul 2026

    Comparative dementia risk associated with SGLT2 inhibitors versus DPP-4 inhibitors in patients with type 2 diabetes following traumatic brain injury: A propensity score–matched Cohort study

    Cohort study

18. Diabetes Obes Metab16 Jul 2026

    Clinical Outcomes for Newly Diagnosed Diabetes Patients in Korea: A National Health Insurance Data

    Cohort study

19. Diabetes Obes Metab16 Jul 2026

    Effectiveness of Telehealth Low‐Carbohydrate Intervention in Preventing Chronic Kidney Disease: A Real‐World, Retrospective, Matched Cohort Study

    Cohort study

20. Diabetes Care15 Jul 2026

    Multiple 24-Hour Urinary Sodium and Potassium Excretions and Type 2 Diabetes Incidence

    Cohort study

21. BMJ Open Diabetes Res Care15 Jul 2026

    Trends in self-reported current diabetes care use, socioeconomic inequalities, and associated factors in Japan: evidence from the Comprehensive Survey of Living Conditions (1986–2022)

    Cross-sectional study

22. Diabetes Obes Metab15 Jul 2026

    Efficacy of DPP ‐4 Inhibitors on Seated and Ambulatory Blood Pressure in Type 2 Diabetes Mellitus

    Meta-analysis

23. Diabet Med15 Jul 2026

    Living with diabetes in the Brazilian Amazon: Exploring barriers and supports for healthy lifestyle practices

    Research article

24. J Clin Endocrinol Metab15 Jul 2026

    Proteomic signatures of loss of glycemic control in youth-onset type 2 diabetes in the TODAY study

    Cohort study

25. Diabetes Res Clin Pract14 Jul 2026

    On target? Cardiovascular risk factor patterns in type 1 and type 2 diabetes: real-world attainment of cardiovascular risk factor targets and medication prescriptions

    Cohort study

26. Diabetes Res Clin Pract14 Jul 2026

    Adherence to diabetes self-care behaviors among patients with diabetes mellitus in Pakistan: a systematic review and meta-analysis

    Meta-analysis

27. Ann Intern Med14 Jul 2026

    Comparative Effectiveness of Glucagon-like Peptide-1 Receptor Agonists Versus Oral Agents for Insulin Discontinuation in Type 2 Diabetes : A Target Trial Emulation

    Research article

28. Diabetes Obes Metab14 Jul 2026

    Effects of GLP ‐1 Receptor Agonists and Dual GIP / GLP ‐1 Receptor Agonists on Inflammatory and Metabolic Biomarkers in Type 2 Diabetes: A Systematic Review and Meta‐Analysis

    Meta-analysis

29. Ann Intern Med14 Jul 2026

    Glucagon-like Peptide-1 Receptor Agonists and Risk for Anterior Ischemic Optic Neuropathy : A Nationwide Cohort Study

    Cohort study

30. Ann Intern Med14 Jul 2026

    Glucagon-like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy : A Target Trial Emulation

    Cohort study

31. Diabetes Res Clin Pract13 Jul 2026

    Safety, tolerability, relative bioavailability, pharmacokinetics, and pharmacodynamics of single and multiple doses of the novel oral bofanglutide in healthy Chinese participants

    Research article

32. Diabetes Res Clin Pract13 Jul 2026

    Predicted risk of death and frequency of outpatient follow-up visits in diabetes clinics. Insight from the large, real-life Italian AMD-Annals database

    Cohort study

33. Diabetes Res Clin Pract13 Jul 2026

    Heterogeneity in type 2 diabetes onset across combinations of lifestyle behaviours in the UK Biobank

    Cohort study

34. Diabetes Res Clin Pract13 Jul 2026

    Healthcare cost trajectories before and after incident cardiovascular disease in type 2 diabetes: A latent class analysis

    Cohort study

35. Diabetes Res Clin Pract13 Jul 2026

    Tirzepatide, cardiovascular outcomes and mortality in obesity and diabetes: a systematic review and meta-analysis

    Meta-analysis

36. Int J Obes (Lond)13 Jul 2026

    Compositional analyses of accelerometer-measured 24-h movement behaviors among adults with normoglycemia, pre-diabetes phenotypes, and diabetes: a population-based study

    Cross-sectional study

37. Diabetes Care13 Jul 2026

    Sarcopenic Obesity and Risk of Incident Type 2 Diabetes: A Prospective Cohort Study and Landmark Analysis From the UK Biobank

    Cohort study

38. Diabetes Obes Metab13 Jul 2026

    Comparative Efficacy of Insulin Delivery Modalities on Glycaemic Control in Adults With Type 2 Diabetes: A Systematic Review and Network Meta‐Analysis

    Meta-analysis

39. Diabetes Obes Metab13 Jul 2026

    Renal Impairment Does Not Affect Pharmacokinetics, Safety or Tolerability of Zenagamtide

    Research article

40. Diabetes Obes Metab13 Jul 2026

    Safety Profile of Tirzepatide in Real‐World Clinical Practice: A Pharmacovigilance Study Using the FAERS Database

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 241–280 of 4,758, newest first